Bernardo Gindri: How platelets Influence Cancer Progression
Bernardo Gindri, Postdoctoral Fellow at NYU Langone Health, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Blood Advances, adding:
“If you want to learn more about how platelets influence cancer progression and antitumor immunity, check out our latest review,
‘Tumor-platelet cross talk in cancer: mechanisms, thrombotic risk, and translational opportunities,’ published in Blood Advances.
We bring together current mechanistic and translational evidence on how tumors reprogram platelets, how platelets shape the tumor microenvironment and metastatic process, and how these interactions may be leveraged for biomarker development and new therapeutic strategies.
Thank you Tessa Barrett for your support and mentorship, and Zihang Li for helping put this work together!”
Title: Tumor-platelet cross talk in cancer: mechanisms, thrombotic risk, and translational opportunities
Authors: Bernardo Gindri dos Santos, Zihang Li, Tessa J. Barrett

Stay updated with Hemostasis Today.
-
Nov 18, 2026, 13:34Vincenzo De Angelis: Strengthening Plasma Management and Quality Control in Eastern Europe
-
Nov 18, 2026, 13:34Standardizing Bleeding Outcome Assessment in Hemophilia Clinical Trials – JTH
-
Nov 18, 2026, 13:34Nicolas Gendron: Towards Sustainable Anticoagulation
-
Nov 18, 2026, 13:33Breaking the Silence on Women and Girls with Bleeding Disorders – EHC
-
Nov 18, 2026, 13:32Maria Elisa Mancuso: Next-Generation Protein Therapies in Hemophilia
-
Nov 18, 2026, 13:25Maia Meier: Advocating for Women and Girls with Bleeding Disorders
-
Nov 18, 2026, 13:19Sjoerd Fabian Koopman: Exploring Tissue Distribution of Extended Half-Life Factor IX Concentrates
-
Nov 18, 2026, 13:16Ifeanyichukwu Ifechidere: Choosing Between Clot-Based and Chromogenic Coagulation Assays
-
Nov 18, 2026, 13:06Saurabh Mehta: Daily Iron Supplementation in Children and Adolescents